Record NNP B-NP O
date NN I-NP O
: : O O
2073-09-15 CD O B-DATE
CARDIOLOGY NN B-NP O
MAHASKA NNP B-NP B-HOSPITAL
COUNTY NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
Reason NN B-NP O
for IN B-PP O
visit NN B-NP O
: : O O
Angiography NNP B-NP O
for IN B-PP O
claudication NN B-NP O
and CC I-NP O
chronic NN I-NP O
renal NN I-NP O
insufficiency NN I-NP O
Interval NNP B-NP O
History NN I-NP O
: : O O
Mr. NNP B-NP O
Vines NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
70 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
male NN I-NP O
who WP B-NP O
has VBZ B-VP O
experienced VBN I-VP O
claudication NN B-NP O
for IN B-PP O
approximately RB B-NP O
five CD I-NP O
to TO B-PP O
six CD B-NP O
years NNS I-NP O
. . O O
He PRP B-NP O
describes VBZ B-VP O
his PRP$ B-NP O
claudication NN I-NP O
as IN B-PP O
bilateral JJ B-NP O
shin NN I-NP O
pain NN I-NP O
which WDT B-NP O
radiates VBZ B-VP O
up RP B-PRT O
to TO B-PP O
his PRP$ B-NP O
knees NNS I-NP O
. . O O
His PRP$ B-NP O
symptoms NNS I-NP O
have VBP B-VP O
worsened VBN I-VP O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
two CD I-NP O
to TO I-NP O
three CD I-NP O
years NNS I-NP O
and CC O O
are VBP B-VP O
now RB I-VP O
limiting VBG I-VP O
his PRP$ B-NP O
lifestyle NN I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
able JJ B-ADJP O
to TO B-VP O
walk VB I-VP O
approximately RB B-NP O
two CD I-NP O
to TO I-NP O
three CD I-NP O
city NN I-NP O
blocks NNS I-NP O
when WRB B-ADVP O
the DT B-NP O
pain NN I-NP O
starts VBZ B-VP O
and CC I-VP O
is VBZ I-VP O
relieved VBN I-VP O
with IN B-PP O
rest NN B-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
rest NN B-NP O
symptoms NNS I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
recently RB I-VP O
evaluated VBN I-VP O
by IN B-PP O
Dr. NNP B-NP O
Curtis NNP I-NP B-DOCTOR
Cochran NNP I-NP I-DOCTOR
for IN B-PP O
his PRP$ B-NP O
claudication NN I-NP O
syjmptoms NNS I-NP O
. . O O
After IN B-PP O
an DT B-NP O
extensive JJ I-NP O
conversation NN I-NP O
and CC O O
a DT B-NP O
review NN I-NP O
of IN B-PP O
hsi NN B-NP O
options NNS I-NP O
, , O O
Mr. NNP B-NP O
Vines NNP I-NP B-PATIENT
decided VBD B-VP O
to TO I-VP O
pursue VB I-VP O
catheter NN B-NP O
based VBN I-NP O
revascularization NN I-NP O
. . O O
He PRP B-NP O
underwent VBD B-VP O
adominal JJ B-NP O
aortography NN I-NP O
and CC O O
iliofemoral JJ B-NP O
angiography NN I-NP O
today NN I-NP O
which WDT B-NP O
demonstrated VBD B-VP O
: : O O
-grossly RB B-ADVP O
patent NN B-VP O
celiac JJ B-NP O
axis NN I-NP O
, , O O
SMA NNP B-NP O
and CC O O
IMA NNP B-NP O
-single JJ B-NP O
renal JJ I-NP O
arteries NNS I-NP O
bilaterally RB B-ADVP O
with IN B-PP O
ostial/proximal JJ B-NP O
65-70 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
on IN B-PP O
the DT B-NP O
left NN I-NP O
; : O O
the DT B-NP O
right JJ I-NP O
renal NN I-NP O
artery NN I-NP O
has VBZ B-VP O
proximal JJ B-NP O
30 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
-diffuse JJ B-NP O
atherosclerosis NN I-NP O
of IN B-PP O
the DT B-NP O
infrarenal JJ I-NP O
abdominal NN I-NP O
aorta NN I-NP O
with IN B-PP O
10-20 CD B-NP O
% NN I-NP O
stenosis NN I-NP O
-right JJ B-NP O
common JJ I-NP O
iliac JJ I-NP O
artery NN I-NP O
diffuse IN B-PP O
20-30 CD B-NP O
% NN I-NP O
stenosis NN I-NP O
-right JJ B-NP O
internal JJ I-NP O
iliac JJ I-NP O
artery NN I-NP O
ostial JJ I-NP O
70 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
-right JJ B-NP O
external JJ I-NP O
iliac JJ I-NP O
artery NN I-NP O
patent NN I-NP O
-right JJ B-NP O
common JJ I-NP O
femoral JJ I-NP O
artery NN I-NP O
patent NN I-NP O
-right JJ B-NP O
profunda NN I-NP O
femoris NN I-NP O
patent NN I-NP O
-right JJ B-NP O
SFA NNP I-NP O
with IN B-PP O
bulky JJ B-NP O
, , I-NP O
calcific JJ I-NP O
eccentric JJ I-NP O
95 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
-left JJ B-NP O
internal JJ I-NP O
iliac JJ I-NP O
ostial JJ I-NP O
40 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
-left JJ B-NP O
external JJ I-NP O
iliac JJ I-NP O
aratery NN I-NP O
patent NN I-NP O
-left JJ B-NP O
common JJ I-NP O
femoral JJ I-NP O
artery NN I-NP O
calcific JJ I-NP O
eccentric JJ I-NP O
70 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
-left JJ B-NP O
profunda NN I-NP O
femoris NN I-NP O
patent NN I-NP O
-diffuse NN B-NP O
left VBD B-VP O
SFA NNP B-NP O
60-70 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
in IN B-PP O
the DT B-NP O
mid JJ I-NP O
vessel NN I-NP O
with IN B-PP O
supraimposed JJ B-NP O
focal JJ I-NP O
80-90 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
-total JJ B-NP O
occlusion NN I-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
popliteal JJ I-NP O
artery NN I-NP O
with IN B-PP O
reconstitution NN B-NP O
at IN B-PP O
the DT B-NP O
TP NNP I-NP O
trunk NN I-NP O
-total JJ B-NP O
occlusion NN I-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
anterior JJ I-NP O
tibial NN I-NP O
artery NN I-NP O
-collaterals NNS B-NP O
reconstitute VBP B-VP O
the DT B-NP O
left JJ I-NP O
peroneal NN I-NP O
and CC O O
posterior JJ B-NP O
tibial NN I-NP O
artery NN I-NP O
Mr. NNP B-NP O
Vines NNP I-NP B-PATIENT
underwent IN B-PP O
dilation NN B-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
femoral JJ I-NP O
artery NN I-NP O
, , O O
dilation NN B-NP O
of IN B-PP O
the DT B-NP O
popliteal JJ I-NP O
occlusion NN I-NP O
and CC O O
overlapping VBG B-VP O
Absolute JJ B-NP O
stents NNS I-NP O
to TO B-PP O
his PRP$ B-NP O
left JJ I-NP O
SFA. NNP I-NP O
He PRP B-NP O
arrives VBZ B-VP O
to TO B-PP O
Internal NNP B-NP O
Medicine NNP I-NP O
mildly RB B-ADVP O
hypertensive VBD B-VP O
with IN B-PP O
SBP NNP B-NP O
140-170s CD I-NP O
. . O O
Past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
: : O O
1 CD B-NP O
. . O O
CAD NNP O O
s/p VBD B-VP O
MI NNP B-NP O
11/72 CD I-NP B-DATE
cath NN B-NP O
11/72 CD I-NP B-DATE
with IN B-PP O
pRCA DT B-NP O
90%-treated JJ I-NP O
with IN B-PP O
stent NN B-NP O
, , O O
LAD NNP B-NP O
50 CD I-NP O
% NN I-NP O
2. . B-NP O
PVD NNP I-NP O
3. . B-NP O
Hyperlipidemia NNP I-NP O
4 CD B-NP O
. . O O
Hypertension NNP O O
5 CD B-NP O
. . O O
Chronic NNP B-NP O
Renal NNP I-NP O
Insufficiency NNP I-NP O
6 CD B-NP O
. . O O
DM NNP B-NP O
Type NNP I-NP O
2 CD O O
7. CD B-NP O
PUD/GIB NN I-NP O
8. . B-NP O
Peripheral NNP I-NP O
Neuropathy NNP I-NP O
9 CD B-LST O
. . O O
s/p NN B-NP O
splenectomy NN I-NP O
10 CD B-LST O
. . O O
s/p NN B-NP O
appendectomy NN I-NP O
Medications NNS B-NP O
( -LRB- B-VP O
home NN B-ADVP O
) -RRB- O O
ECASA NNP B-NP O
325 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd . O O
Toprol NNP B-NP O
XL NNP I-NP O
50mg CD I-NP O
po NN I-NP O
qd NN I-NP O
Lisinopril NNP B-NP O
40mg CD I-NP O
po NN I-NP O
qd NN I-NP O
Lipitor NNP B-NP O
40mg CD I-NP O
po NN I-NP O
qd NN I-NP O
Nexium NNP B-NP O
20mg CD I-NP O
po NN I-NP O
qd NN I-NP O
Ferrous JJ B-NP O
Gluconate NNP I-NP O
325mg CD I-NP O
po NN I-NP O
bid NN I-NP O
Imdur NNP B-NP O
30mg CD I-NP O
po NN I-NP O
qd NN I-NP O
Humulin NNP B-NP O
10-20 CD I-NP O
units NNS I-NP O
qam . O O
Humulin NNP B-NP O
30-35 CD I-NP O
units NNS I-NP O
qpm . O O
Allergies NNP B-NP O
: : O O
Penicillin NNP B-NP O
allergy NN I-NP O
He PRP B-NP O
has VBZ B-VP O
penicillin NN B-NP O
allergies NNS I-NP O
which WDT B-NP O
causes VBZ B-VP O
rash NN B-NP O
. . O O
Family NNP B-NP O
history NN I-NP O
: : O O
Mother NN B-NP O
died VBD B-VP O
in IN B-PP O
her PRP$ B-NP O
50s NNS I-NP B-AGE
of IN B-PP O
CAD NNP B-NP O
, , O O
multiple JJ B-NP O
siblings NNS I-NP O
with IN B-PP O
CAD NN B-NP O
Social JJ B-NP O
history NN I-NP O
: : O O
He PRP B-NP O
had VBD B-VP O
a DT B-NP O
100-pack-year JJ I-NP O
smoking NN I-NP O
history NN I-NP O
and CC O O
quit VBD B-VP O
since IN B-PP O
his PRP$ B-NP O
hospitalization NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
not RB I-VP O
had VBN I-VP O
any DT B-NP O
cigarettes NNS I-NP O
since IN B-PP O
discharge NN B-NP O
from IN B-PP O
the DT B-NP O
hospitalization NN I-NP O
. . O O
He PRP B-NP O
drinks VBZ B-VP O
alcohol NN B-NP O
occasionally RB I-NP O
and CC O O
currently RB B-VP O
is VBZ I-VP O
employed VBN I-VP O
as IN B-PP O
an DT B-NP O
editor NN I-NP B-PROFESSION
and CC O O
works VBZ B-VP O
about IN B-NP O
10 CD I-NP O
hours NNS I-NP O
per IN B-PP O
week NN B-NP O
and CC O O
during IN B-PP O
the DT B-NP O
day NN I-NP O
usually RB B-ADVP O
takes VBZ B-VP O
care NN B-NP O
of IN B-PP O
his PRP$ B-NP O
grandchildren NNS I-NP O
, , O O
and CC O O
he PRP B-NP O
currently RB B-VP O
lives VBZ I-VP O
in IN B-PP O
New NNP B-NP B-CITY
Haven NNP I-NP I-CITY
. . O O
Review NNP B-NP O
of IN B-PP O
systems NNS B-NP O
: : O O
GEN:denies NNS B-NP O
fever NN I-NP O
, , O O
chills NNS B-NP O
, , O O
weight NN B-NP O
loss NN I-NP O
RESP NNP B-NP O
: : O O
denies VBZ B-VP O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
, , O O
PND NNP B-NP O
, , O O
orthopnea NN B-NP O
, , O O
cough NN B-NP O
CV NNP B-NP O
: : O O
denies VBZ B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
LE JJ B-NP O
edema NN I-NP O
, , O O
+claudication NN B-NP O
as IN B-PP O
per IN B-NP O
HPI NN I-NP O
GI NNP B-NP O
: : O O
recent JJ B-NP O
treatment NN I-NP O
for IN B-PP O
H.Pylori NNP B-NP O
, , O O
denies VBZ B-VP O
nausea NN B-NP O
, , O O
vomiting VBG B-VP O
, , O O
constipation NN B-NP O
, , O O
diarrhea NN B-NP O
, , O O
BRBPR NN B-NP O
GU NNP B-NP O
: : O O
denies VBZ B-VP O
hematuria NN B-NP O
, , O O
dysuria NN B-NP O
NEURO NNP B-NP O
: : O O
denies VBZ B-VP O
TIA NNP B-NP O
, , O O
CVA NNP B-NP O
Physical JJ B-NP O
examination NN I-NP O
: : O O
-BP JJ B-NP O
: : O O
left JJ B-NP O
arm NN I-NP O
178/80 CD B-NP O
, , O O
right JJ B-ADVP O
arm NN B-VP O
174/8 CD B-NP O
0 CD I-NP O
-Chest NN B-NP O
: : O O
Lungs NNP B-NP O
are VBP B-VP O
clear JJ B-ADJP O
to TO B-PP O
auscultation NN B-NP O
( -LRB- I-NP O
anteriorly RB I-NP O
) -RRB- O O
-Cardiac JJ B-NP O
: : O O
RRR NNP B-NP O
S1 NNP I-NP O
S2 . O O
early RB B-NP O
systolic JJ I-NP O
ejection NN I-NP O
mumur NN I-NP O
, , O O
no DT B-NP O
rubs NNS I-NP O
or CC I-NP O
gallops NNS I-NP O
-Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
nontender NN B-NP O
, , O O
+bowel NN B-NP O
sounds NNS I-NP O
, , O O
unable JJ B-ADJP O
to TO B-VP O
appreciate VB I-VP O
abdominal JJ B-NP O
bruit NN I-NP O
-Pulse NN B-NP O
: : O O
62 CD O O
-General JJ B-NP O
: : O O
Pleasant NNP B-NP O
male NN I-NP O
in IN B-PP O
NAD NNP B-NP O
lying VBG B-VP O
falt JJ B-NP O
post NN I-NP O
procedure NN I-NP O
-Neck NN B-NP O
: : O O
Carotids NNP B-NP O
2+ CD I-NP O
, , O O
normal JJ B-ADJP O
upstrokes RB B-ADVP O
, , O O
+ IN B-PP O
bilateral JJ B-NP O
carotid NN I-NP O
bruits NNS I-NP O
R NN I-NP O
> VBZ B-VP O
L, NNP B-NP O
JVP NNP I-NP O
6cm . O O
-Extremities NNS B-NP O
: : O O
Right RB B-ADVP O
femoral JJ B-NP O
1+ NNS I-NP O
, , O O
no DT B-NP O
bruit NN I-NP O
, , O O
no DT B-NP O
hematoma NN I-NP O
, , O O
PT NNP B-NP O
1+ CD I-NP O
, , O O
DP NNP B-NP O
1+ VBD B-VP O
, , O O
Left VBD B-VP O
femoral JJ B-NP O
1+ JJ I-NP O
, , I-NP O
soft JJ I-NP O
bruit NN I-NP O
, , O O
PT NNP B-NP O
1+ CD I-NP O
, , O O
DP NNP B-NP O
1+ VBD B-VP O
, , O O
no DT B-NP O
ulcers NNS I-NP O
-resp. DT B-NP O
rate NN I-NP O
: : O O
18 CD O O
-weight NN B-NP O
: : O O
191 CD B-NP O
lbs NNS I-NP O
. . O O
-height NN B-NP O
: : O O
71 CD B-NP O
in IN B-ADVP O
. . O O
-BMI JJ B-NP O
: : O O
26.7 CD B-NP O
Overweight NN I-NP O
, , O O
moderate JJ B-NP O
risk NN I-NP O
-Neuro NNP B-NP O
: : O O
Alert NNP B-NP O
and CC O O
oriented VBN B-VP O
X NNP B-NP O
3 CD I-NP O
, , O O
grossly RB B-NP O
intact JJ I-NP O
Selected NNP B-NP O
recent JJ I-NP O
labs NNS I-NP O
: : O O
09/10/73 CD B-NP B-DATE
- : O O
NA NNP B-NP O
142 CD I-NP O
, , O O
K NNP B-NP O
4.5 CD I-NP O
, , O O
CL VBZ B-VP O
108 CD B-NP O
, , O O
CO2 NNP B-NP O
23.9 CD I-NP O
, , O O
BUN NNP B-NP O
37 CD I-NP O
, , O O
CRE NNP B-NP O
1.5 CD I-NP O
, , O O
GLU NNP B-NP O
106 CD I-NP O
, , O O
CA NNP B-NP O
9.7 CD I-NP O
, , O O
HCT NNP B-NP O
37.2 CD I-NP O
, , O O
RBC NNP B-NP O
4.09 CD I-NP O
, , O O
WBC NNP B-NP O
9.4 CD I-NP O
, , O O
PLT NNP B-NP O
309 CD I-NP O
, , O O
ALYMP NNP B-NP O
4.00 CD I-NP O
, , O O
%MONO NNP B-NP O
8 CD I-NP O
, , O O
%EOS CC O O
3 CD B-NP O
, , O O
%BASO NNP B-NP O
1 CD I-NP O
, , O O
PT NNP B-NP O
12.4 CD I-NP O
, , O O
PTT NNP B-NP O
26.1 CD I-NP O
07/24/73 CD B-NP B-DATE
- : O O
HGBA1C JJ B-NP O
8.10 CD I-NP O
07/22/73 CD B-NP B-DATE
- : O O
CHOL JJ B-NP O
148 CD I-NP O
, , O O
TRIG NNP B-NP O
137 CD I-NP O
, , O O
HDL NNP B-NP O
50 CD I-NP O
, , O O
LDL NNP B-NP O
71 CD I-NP O
05/08/73 CD B-NP B-DATE
- : O O
PHOS NNS B-NP O
2.1 CD B-NP O
, , O O
MG NNP B-NP O
1.4 CD I-NP O
, , O O
PT-INR NNP B-NP O
1.1 CD I-NP O
05/06/73 CD B-NP B-DATE
- : O O
UA-GLUC JJ B-NP O
NEGATIVE JJ I-NP O
, , I-NP O
UA-SPGR NNP I-NP O
>1.030 CD I-NP O
, , O O
UA-BLD NNP B-NP O
NEGATIVE NNP I-NP O
, , O O
UA-PH NNP B-NP O
5.0, CD I-NP O
UA-ALB NNP I-NP O
, , I-NP O
UA-NIT NNP I-NP O
NEGATIVE CD I-NP O
04/28/73 CD B-NP B-DATE
- : O O
TSH NNS B-NP O
0.62 CD B-NP O
Assessment NNP B-NP O
and CC I-NP O
plan NN I-NP O
: : O O
Mr. NNP B-NP O
Vines NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
70 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
male NN I-NP O
who WP B-NP O
presents VBZ B-VP O
today NN B-NP O
for IN B-PP O
angiograpy NN B-NP O
for IN B-PP O
lifestyle NN B-NP O
limiting VBG I-NP O
claudication NN I-NP O
. . O O
He PRP B-NP O
underwent VBD B-VP O
dilation NN B-NP O
of IN B-PP O
his PRP$ B-NP O
left JJ I-NP O
common JJ I-NP O
femoral JJ I-NP O
artery NN I-NP O
, , O O
dilation NN B-NP O
of IN B-PP O
his PRP$ B-NP O
popliteal JJ I-NP O
occlusion NN I-NP O
and CC I-NP O
placement NN I-NP O
of IN B-PP O
two CD B-NP O
overlapping JJ I-NP O
Absolute JJ I-NP O
stents NNS I-NP O
to TO B-PP O
his PRP$ B-NP O
left JJ I-NP O
SFA. NNP I-NP O
There EX I-NP O
will MD B-VP O
be VB I-VP O
further JJ B-NP O
discussion NN I-NP O
to TO B-VP O
undergo VB I-VP O
a DT B-NP O
staged VBN I-NP O
intervention NN I-NP O
of IN B-PP O
his PRP$ B-NP O
left JJ I-NP O
reanl NN I-NP O
artery NN I-NP O
and CC O O
right JJ B-NP O
SFA NNP I-NP O
calcific JJ I-NP O
lesions NNS I-NP O
as IN B-PP O
an DT B-NP O
outpatient NN I-NP O
. . O O
1 LS O O
. . O O
PVD-Plan NNP O O
to TO B-VP O
continue VB I-VP O
current JJ B-NP O
medical JJ I-NP O
regimen NNS I-NP O
. . O O
Plan NN B-NP O
for IN B-PP O
Plavix NNP B-NP O
for IN B-PP O
one CD B-NP O
month NN I-NP O
. . O O
Further RB O O
discussions NNS B-NP O
of IN B-PP O
his PRP$ B-NP O
left JJ I-NP O
renal JJ I-NP O
artery NN I-NP O
and CC O O
right JJ B-NP O
SFA NNP I-NP O
lesions NNS I-NP O
to TO B-VP O
be VB I-VP O
discussed VBN I-VP O
as IN B-PP O
an DT B-NP O
outpatient NN I-NP O
. . O O
Patient NNP B-NP O
would MD B-VP O
benefit VB I-VP O
from IN B-PP O
CNIS NNP B-NP O
due JJ I-NP O
t IN B-PP O
his PRP$ B-NP O
bilateral JJ I-NP O
carotid NN I-NP O
stenoses NNS I-NP O
but CC O O
may MD B-VP O
obtain VB I-VP O
as IN B-PP O
an DT B-NP O
outpatient NN I-NP O
. . O O
2. . B-NP O
CARDIAC NNP I-NP O
ISCHEMIA-No NN B-NP O
symptoms NNS I-NP O
. . O O
Continue NNP O O
his PRP$ B-NP O
current JJ I-NP O
regimen NNS I-NP O
. . O O
His PRP$ B-NP O
recent JJ I-NP O
lipid JJ I-NP O
panel NN I-NP O
is VBZ B-VP O
at IN B-PP O
target NN B-NP O
. . O O
PUMP-Euvolemic JJ B-ADJP O
on IN B-PP O
exam NN B-NP O
. . O O
Hypertensive NNP B-NP O
on IN B-PP O
arrival NN B-NP O
to TO B-PP O
unit NN B-NP O
and CC O O
received VBD B-VP O
additional JJ B-NP O
nitrates NNS I-NP O
. . O O
Will MD B-VP O
monitor VB I-VP O
response NN B-NP O
and CC O O
consider VBP B-VP O
added VBN I-VP O
Norvasc NNP B-NP O
. . O O
RATE/RHYTHM-Well NN B-NP O
controlled VBN B-VP O
on IN B-PP O
Toprol NNP B-NP O
. . O O
3. DT B-NP O
RENAL-Patient JJ I-NP O
received VBN I-NP O
sodium NN I-NP O
bicarbonate NN I-NP O
drip NN I-NP O
for IN B-PP O
renal JJ B-NP O
protection NN I-NP O
. . O O
Plan NNP O O
to TO B-VP O
add VB I-VP O
mucomyst NN B-NP O
. . O O
Monitor '' O O
renal JJ B-NP O
function NN I-NP O
and CC O O
urine JJ B-NP O
output NN I-NP O
. . O O
Continue VB B-VP O
lisinopril NN B-NP O
as IN B-SBAR O
he PRP B-NP O
as RB B-VP O
been VBN I-VP O
taking VBG I-VP O
this DT B-NP O
as IN B-PP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
tolerating VBG B-VP O
it PRP B-NP O
. . O O
4 CD B-LST O
. . O O
PUD-Continue NNP B-NP O
PPI. NNP I-NP O
5 CD B-NP O
. . O O
DISPO-Anticipate NNP B-NP O
discharge NN I-NP O
home NN I-NP O
in IN B-PP O
the DT B-NP O
am VBP I-NP O
and CC O O
follow-up JJ B-ADJP O
with IN B-PP O
Dr. NNP B-NP O
Cochran NNP I-NP B-DOCTOR
and CC O O
his PRP$ B-NP O
cardiologist NN I-NP O
Edward NNP I-NP B-DOCTOR
Benitez NNP I-NP I-DOCTOR
. . O O
Further JJ B-NP O
plans NNS I-NP O
per IN B-PP O
Dr. NNP B-NP O
Cochran NNP I-NP B-DOCTOR
. . O O
Patricia NNP B-NP B-DOCTOR
N. NNP I-NP I-DOCTOR
Vallejo NNP I-NP I-DOCTOR
ACNP-BC . O O
Signed VBN B-VP O
electronically RB B-ADVP O
by IN B-PP O
Patricia NNP B-NP B-DOCTOR
N NNP I-NP I-DOCTOR
Vallejo NNP I-NP I-DOCTOR
MS NNP I-NP O
,RN,ACNP NNP I-NP O
on IN B-PP O
Sep NNP B-NP B-DATE
15 CD I-NP I-DATE
, , I-NP I-DATE
2073 CD O I-DATE
